UNH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
UnitedHealth Group Inc (UNH) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows some positive signs like improved financials, raised analyst price targets, and a potential turnaround story, the technical indicators suggest the stock is currently overbought. Additionally, the stock's recent performance and lack of significant trading trends or strong proprietary trading signals indicate that waiting for a better entry point might be more prudent.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 93.915, which signals the stock is overbought. Moving averages are converging, showing no clear trend direction. The stock is trading near resistance levels (R1: 350.553, R2: 363.685), suggesting limited immediate upside potential.
Analysts have raised price targets significantly, with several firms maintaining Buy or Overweight ratings.
The company reported strong Q1 results, with raised guidance for FY26 and FY
UnitedHealth announced plans to standardize over 70% of its prior authorization volume by 2026, improving operational efficiency.
The stock has declined by 0.6% over the past six months, underperforming its peers.
Insider and hedge fund trading trends are neutral, showing no significant buying interest.
The RSI indicates the stock is overbought, suggesting potential for a short-term pullback.
In Q1 2026, revenue increased by 1.96% YoY to $111.72 billion, and EPS grew by 0.73% YoY to 6.9. However, net income slightly declined by -0.19% YoY to $6.28 billion. The financials show modest growth but do not indicate a significant breakout performance.
Analysts have raised price targets across the board, with targets ranging from $337 to $420. Many firms maintain Buy or Overweight ratings, citing strong Q1 results, raised guidance, and a multi-year turnaround story. However, some firms remain cautious, with Hold or Neutral ratings, citing conservative guidance and higher costs.
